Phreesia, Inc. (NYSE:PHR) CFO Sells $22,555.28 in Stock

Phreesia, Inc. (NYSE:PHR) CFO Balaji Gandhi sold 836 shares of the company’s stock in a transaction that occurred on Wednesday, January 15th. The stock was sold at an average price of $26.98, for a total value of $22,555.28. Following the sale, the chief financial officer now owns 147,673 shares of the company’s stock, valued at $3,984,217.54. This trade represents a 0.56 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Balaji Gandhi also recently made the following trade(s):

• On Monday, January 6th, Balaji Gandhi sold 3,195 shares of Phreesia stock. The shares were sold at an average price of $26.61, for a total transaction of $85,018.95.

Phreesia Stock Up 1.6 %

NYSE:PHR traded up $0.44 during mid-day trading on Friday, hitting $27.24. The company had a trading volume of 309,924 shares, compared to its average volume of 382,284. Phreesia, Inc. has a 1 year low of $17.07 and a 1 year high of $29.16. The business has a fifty day simple moving average of $23.42 and a 200-day simple moving average of $22.77. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04. The firm has a market capitalization of $1.58 billion, a price-to-earnings ratio of -18.53 and a beta of 0.94.

Phreesia (NYSE:PHR) last released its quarterly earnings results on Monday, December 9th. The company reported ($0.25) EPS for the quarter, topping the consensus estimate of ($0.29) by $0.04. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The firm had revenue of $106.80 million for the quarter, compared to analyst estimates of $106.33 million. During the same period in the previous year, the company posted ($0.58) EPS. Phreesia’s revenue for the quarter was up 16.6% on a year-over-year basis. Equities analysts forecast that Phreesia, Inc. will post -1.1 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the company. Versor Investments LP acquired a new position in Phreesia in the 3rd quarter worth $694,000. Zacks Investment Management acquired a new position in shares of Phreesia in the third quarter worth about $631,000. Sei Investments Co. boosted its holdings in Phreesia by 135.3% in the second quarter. Sei Investments Co. now owns 165,327 shares of the company’s stock valued at $3,505,000 after purchasing an additional 95,058 shares during the last quarter. State Street Corp boosted its holdings in Phreesia by 7.1% in the third quarter. State Street Corp now owns 1,327,586 shares of the company’s stock valued at $30,256,000 after purchasing an additional 88,517 shares during the last quarter. Finally, Franklin Resources Inc. boosted its holdings in Phreesia by 3.0% in the third quarter. Franklin Resources Inc. now owns 1,497,631 shares of the company’s stock valued at $31,495,000 after purchasing an additional 42,973 shares during the last quarter. 92.10% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

PHR has been the topic of several analyst reports. Royal Bank of Canada raised shares of Phreesia from a “sector perform” rating to an “outperform” rating and lifted their target price for the company from $24.00 to $32.00 in a report on Wednesday, January 8th. KeyCorp increased their target price on Phreesia from $28.00 to $30.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 8th. Citigroup lifted their price target on Phreesia from $31.00 to $35.00 and gave the company a “buy” rating in a research note on Friday, January 10th. Robert W. Baird cut their price target on Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a research note on Wednesday, December 11th. Finally, Truist Financial boosted their target price on shares of Phreesia from $31.00 to $34.00 and gave the company a “buy” rating in a research note on Wednesday, December 11th. Twelve research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Phreesia has a consensus rating of “Buy” and an average target price of $31.00.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.